We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
226
Abivax
ABVX
$10.7B
$275K 0.09%
+3,250
New +$199K
DMYY
227
DELISTED
dMY Squared
DMYY
$271K 0.09%
22,055
+2,054
+10% +$26.4K
UVXY icon
228
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$279M
$271K 0.09%
5,200
+2,100
+68% +$146K
SVIIR
229
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$270K 0.09%
+538,000
New +$174K
SBGI icon
230
Sinclair Inc
SBGI
$1.02B
$267K 0.09%
+17,745
New +$255K
FICO icon
231
Fair Isaac
FICO
$23.9B
$266K 0.09%
178
-372
-68% -$559K
GTLB icon
232
GitLab
GTLB
$7.21B
$260K 0.08%
5,774
+2,774
+92% +$127K
HUM icon
233
Humana
HUM
$46.1B
$260K 0.08%
1,000
+500
+100% +$131K
AMRZ
234
Amrize Ltd
AMRZ
$25.7B
$251K 0.08%
5,180
-2,340
-31% -$119K
ARE icon
235
Alexandria Real Estate Equities
ARE
$8.33B
$250K 0.08%
3,000
+1,900
+173% +$152K
OXY icon
236
Occidental Petroleum
OXY
$57.7B
$246K 0.08%
5,223
+5,083
+3,631% +$230K
WDAY icon
237
Workday
WDAY
$51.5B
$244K 0.08%
+1,014
New +$234K
NU icon
238
Nu Holdings
NU
$67.3B
$240K 0.08%
15,000
+11,658
+349% +$163K
ECHO
239
EchoStar
ECHO
$26.7B
$239K 0.08%
+3,130
New +$142K
MO icon
240
Altria Group
MO
$109B
$237K 0.08%
3,600
-9,657
-73% -$612K
YCS icon
241
ProShares UltraShort Yen
YCS
$30M
$236K 0.08%
+5,300
New +$232K
HAE icon
242
Haemonetics
HAE
$4.12B
$233K 0.07%
+4,800
New +$297K
BBY icon
243
Best Buy
BBY
$18.1B
$232K 0.07%
+3,068
New +$220K
MCK icon
244
McKesson
MCK
$100B
$231K 0.07%
300
+100
+50% +$70.4K
TMO icon
245
Thermo Fisher Scientific
TMO
$220B
$230K 0.07%
+475
New +$221K
FYBR
246
DELISTED
Frontier Communications
FYBR
$229K 0.07%
6,138
-39,732
-87% -$1.47M
VOYG
247
Voyager Technologies
VOYG
$2.69B
$229K 0.07%
7,707
-16,128
-68% -$558K
JKS
248
JinkoSolar
JKS
$854M
$225K 0.07%
+9,400
New +$222K
AMD icon
249
Advanced Micro Devices
AMD
$796B
$223K 0.07%
1,382
-3,480
-72% -$562K
LITE icon
250
Lumentum
LITE
$78.8B
$221K 0.07%
1,364
+964
+241% +$120K
8 9
10
11 12

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.